Johnson & Johnson (JNJ) FCF Payout Ratio Growth (5y) (2014 - 2026)

Johnson & Johnson (JNJ) FCF Payout Ratio Growth (5y) (2014 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Mar 29, 2026 22.25%
Dec 28, 2025 8.61%
Sep 28, 2025 2.37%
Jun 29, 2025 2.98%
Mar 30, 2025 -0.71%
Dec 29, 2024 2.69%
Sep 29, 2024 3.07%
Jun 30, 2024 5.37%
Mar 31, 2024 3.94%
Dec 31, 2023 -1.38%
Oct 1, 2023 -0.12%
Jul 2, 2023 16.85%
Apr 2, 2023 9.97%
Jan 1, 2023 33.59%
Apr 3, 2022 -2.18%
Apr 4, 2021 -10.13%
Sep 27, 2020 -2.16%
Jun 28, 2020 16.63%
Mar 29, 2020 1.87%
Dec 29, 2019 -5.02%